deferiprone has been researched along with Acrania in 3 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kontoghiorghes, GJ | 3 |
| Bartlett, AN | 1 |
| Hoffbrand, AV | 3 |
| Aldouri, MA | 2 |
| Sheppard, L | 2 |
| Barr, J | 1 |
| Wonke, B | 1 |
| Kourouclaris, T | 1 |
1 trial available for deferiprone and Acrania
| Article | Year |
|---|---|
Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ascorbic Acid; Clinical Trials as Topic; Deferiprone; | 1987 |
2 other studies available for deferiprone and Acrania
| Article | Year |
|---|---|
Prospects for effective oral iron chelation therapy in man with 1,2-dimethyl-3-hydroxypyrid-4-one and other alpha-ketohydroxypyridines.
Topics: Adult; Aged; Blood Transfusion; Deferiprone; Humans; Iron; Iron Chelating Agents; Middle Aged; Neura | 1989 |
1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for treatment of iron overload.
Topics: Administration, Oral; Aged; Aged, 80 and over; Capsules; Deferiprone; Dose-Response Relationship, Dr | 1987 |